Thermo Fisher Scientific Financials

Market Capitalization $222.61 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	33.44
Forward PE	23.50
Price to Sales TTM	$4.98
Price to Book MRQ	$4.27
Enterprise to Revenue	5.72
Enterprise to EBITDA	23.07

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	15.02%
Operating Margin	19.28%
Return on Assets TTM	4.94%
Return on Equity TTM	13.12%

Income Statement

Revenue TTM	$43,735,998,464
Revenue per Share TTM	$115.40
Quarterly Revenue Growth	4.90%
Gross Profit TTM	$18,101,999,616
EBITDA	$11,783,000,000
Net Income to Common TTM	$6,569,999,872
Diluted EPS TTM	$17.33
Quarterly Earnings Growth YoY	-0.90%

Balance Sheet

Total Cash MRQ	$3,545,999,872
Total Cash per Share MRQ	$9.44
Total Debt MRQ	$
Total Debt to Equity MRQ	69.75
Current Ratio MRQ	1.50
Book Value per Share MRQ	$135.79

Cash Flow

Operating Cash Flow TTM	$7,650,999,808
Levered Free Cash Flow TTM	$4,696,750,080

TMO Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	375,708,059
Float Shares	374,795,088
Avg 10 Volume	1,360,630
Avg 30 Volume	None
Shares Short	5,086,563
Short Ratio	3.22
Short % of Shares	1.36%
% Held by Insiders	0.15%
% Held by Institutions	92.83%

Stock Price Summary

Beta	0.90
Fifty Two Week Low	$385.46
Fifty Two Week High	$610.97
Fifty Two Week Change	10.21%
Day 50 MA	$574.33
Day 200 MA	$485.19

Dividends and Splits

Forward Annual Dividend Rate	$1.72
Forward Annual Dividend Yield	0.29%
Trailing Annual Dividend Rate	$1.72
Trailing Annual Dividend Yield	0.29%
Payout Ratio	9.71%
Dividend Date	2026-01-15
Ex Dividend Date	2025-12-15
Last Split Factor
Last Split Date	1996-06-06